Price cuts put pressure on South Korean pharma
This article was originally published in Scrip
Executive Summary
The South Korean pharmaceutical market was valued at around $11 billion in 2010 with 10% growth forecast through 2014, driven by a rapidly ageing population, increasing prevalence of chronic disease, harmonisation with international standards and strengthening international trade relationships.